UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

The American journal of psychiatry, 2014-02, Vol.171 (2), p.160-168

2014

Volltextzugriff (PDF)

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia

European psychiatry, 2022-03, Vol.65 (1), Article e23

2022

Volltextzugriff (PDF)

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies

European psychiatry, 2021-05, Vol.64 (1), p.e35, Article e35

2021

Volltextzugriff (PDF)

Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis

Clinical therapeutics, 2016-01, Vol.38 (1), p.4-15

2016

Volltextzugriff (PDF)

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

CNS spectrums, 2014-08, Vol.19 (4), p.330-339

2014

Volltextzugriff (PDF)

Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study

Neurology and therapy, 2021-06, Vol.10 (1), p.121-147

2021

Volltextzugriff (PDF)

Natural History of Streptococcus sanguinis in the Oral Cavity of Infants: Evidence for a Discrete Window of Infectivity

Infection and Immunity, 2000-07, Vol.68 (7), p.4018-4023

2000

Volltextzugriff (PDF)

Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis

Schizophrenia research, 2022-02, Vol.240, p.205-213

2022

Volltextzugriff (PDF)

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

Journal of psychiatric research, 2013-05, Vol.47 (5), p.670-677

2013

Volltextzugriff (PDF)

Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study

CNS spectrums, 2021-04, Vol.26 (2), p.147-147

2021

Volltextzugriff (PDF)

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study

The journal of clinical psychiatry, 2013-05, Vol.74 (5), p.507-515

2013

Volltextzugriff (PDF)

The development of lurasidone for bipolar depression

Annals of the New York Academy of Sciences, 2015-11, Vol.1358 (1), p.95-104

2015

Volltextzugriff (PDF)

4.51 LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAÏVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY

Journal of the American Academy of Child and Adolescent Psychiatry, 2019-10, Vol.58 (10), p.S236-S236

2019

Volltextzugriff (PDF)

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study

The journal of clinical psychiatry, 2013-02, Vol.74 (2), p.170-179

2013

Volltextzugriff (PDF)

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

CNS spectrums, 2016-10, Vol.21 (5), p.393-402

2016

Volltextzugriff (PDF)

F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY

Schizophrenia bulletin, 2019-04, Vol.45 (Supplement_2), p.S293-S294

2019

Volltextzugriff (PDF)

Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial

International clinical psychopharmacology, 2021-05, Vol.36 (3), p.117-125

2021

Volltextzugriff (PDF)

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension

European neuropsychopharmacology, 2013-11, Vol.23 (11), p.1373-1382

2013

Volltextzugriff (PDF)

Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia

General hospital psychiatry, 2017-07, Vol.47, p.75-82

2017

Volltextzugriff (PDF)

Poster #T55 EFFECT OF LURASIDONE ON DEPRESSIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA

Schizophrenia research, 2014-04, Vol.153, p.S308-S308

2014

Volltextzugriff (PDF)

Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial

Journal of child and adolescent psychopharmacology, 2019-03, Vol.29 (2), p.80-89

2019

Volltextzugriff (PDF)

104 Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents with Schizophrenia: Analysis of a Two-Year Study

CNS spectrums, 2020-04, Vol.25 (2), p.267-268

2020

Volltextzugriff (PDF)

T5. LURASIDONE AND RISK FOR METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA: A COMPREHENSIVE DATABASE ANALYSIS

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S114-S114

2018

Volltextzugriff (PDF)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study

Journal of attention disorders, 2020-01, Vol.24 (2), p.192-204

2020

Volltextzugriff (PDF)

A third-generation SPARC V9 64-b microprocessor

IEEE journal of solid-state circuits, 2000-11, Vol.35 (11), p.1526-1538

2000

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(487)
Mit Volltextzugriff
(500)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(380)
Life Sciences & Biomedicine
(225)
Humans
(157)
Technology
(124)
Male
(83)
Female
(78)
Physical Sciences
(69)
Engineering
(57)
Animals
(50)
Adult
(43)
Computer Science
(41)
Middle Aged
(36)
Physics
(33)
Science & Technology - Other Topics
(33)
Biological And Medical Sciences
(32)
Materials Science
(31)
Engineering, Electrical & Electronic
(30)
Medical Sciences
(27)
Psychiatry
(27)
Exact Sciences And Technology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(251)
EZB Electronic Journals Library
(209)
MEDLINE
(201)
Journals@Ovid
(156)
Elsevier ScienceDirect Journals
(123)
Single Journals
(111)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(75)
IngentaConnect Journals
(71)
IEEE Electronic Library Online
(70)
Wiley-Blackwell Journals
(47)
Springer journals
(41)
Wiley Online Library Full Collection 2018
(35)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(21)
Oxford journals
(21)
JSTOR
(21)
Oxford Journals 2020 Medicine
(19)
Taylor & Francis Journals
(17)
eBooks on EBSCOhost
(17)
Nature
(16)
Taylor & Francis
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies

Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study

Natural History of Streptococcus sanguinis in the Oral Cavity of Infants: Evidence for a Discrete Window of Infectivity

Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study

The development of lurasidone for bipolar depression

4.51 LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAÏVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY

Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension

Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia

Poster #T55 EFFECT OF LURASIDONE ON DEPRESSIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA

Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial

104 Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents with Schizophrenia: Analysis of a Two-Year Study

T5. LURASIDONE AND RISK FOR METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA: A COMPREHENSIVE DATABASE ANALYSIS

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study

A third-generation SPARC V9 64-b microprocessor

Suchergebnisse filtern